HEALTHCARE SPENDING IN SWITZERLAND ACCOUNTS FOR 11.1% OF GDP

Research and Markets has announced the addition of the new report from Espicom Business Intelligence Ltd entitled "Switzerland Generics Market Intelligence Report" to their offering. Depending on your viewpoint, generic drugs represent either the future of the global pharmaceutical industry or an irritating drain on the revenues of R&D based companies.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2762697)